Literature DB >> 21146588

Normal delay eyeblink conditioning in mice devoid of astrocytic S100B.

Hye-Soo R Kim1, Akiko Seto-Ohshima, Hiroshi Nishiyama, Shigeyoshi Itohara.   

Abstract

S100B is a small calcium binding protein synthesized and secreted mostly by astrocytes. Mice devoid of S100B (S100B-KO) develop without detectable anatomic abnormalities of the brain, but exhibit enhanced hippocampal long-term potentiation and enhanced performance in hippocampus-dependent learning and memory tasks, indicating that S100B has a crucial role in hippocampal neuronal plasticity. In the present study, we examined whether S100B has a similar role in the cerebellar regions, because Bergmann glia, a specialized subset of astrocytes in the cerebellar cortex, express a particularly large amount of S100B under physiologic conditions. Unlike in the hippocampus-dependent tasks, S100B-KO mice were indistinguishable from wild-type mice in both cerebellum-dependent motor coordination and delay eyeblink conditioning, a well-established paradigm for cerebellum-dependent learning and memory. These results suggest that S100B has differential roles in the hippocampus and cerebellum.
© 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21146588     DOI: 10.1016/j.neulet.2010.12.005

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

1.  Normal cerebellar development in S100B-deficient mice.

Authors:  Björn Bluhm; Björn Laffer; Daniela Hirnet; Matthias Rothermundt; Oliver Ambree; Christian Lohr
Journal:  Cerebellum       Date:  2015-04       Impact factor: 3.847

2.  In vivo screening of S100B inhibitors for melanoma therapy.

Authors:  Danna B Zimmer; Rena G Lapidus; David J Weber
Journal:  Methods Mol Biol       Date:  2013

3.  Zinc Binding to S100B Affords Regulation of Trace Metal Homeostasis and Excitotoxicity in the Brain.

Authors:  Simone Hagmeyer; Joana S Cristóvão; John J E Mulvihill; Tobias M Boeckers; Cláudio M Gomes; Andreas M Grabrucker
Journal:  Front Mol Neurosci       Date:  2018-01-17       Impact factor: 5.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.